scholarly article | Q13442814 |
P356 | DOI | 10.1161/01.CIR.79.5.1091 |
P698 | PubMed publication ID | 2713975 |
P2093 | author name string | R Davis | |
J E Lock | |||
J F Keane | |||
R Van Praagh | |||
J J Rome | |||
S B Perry | |||
S Van Praagh | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1091-1099 | |
P577 | publication date | 1989-05-01 | |
P1433 | published in | Circulation | Q578091 |
P1476 | title | Transcatheter closure of atrial septal defects. Experimental studies | |
P478 | volume | 79 |
Q34069333 | A European multicentric experience using the CardioSEal and Starflex double umbrella devices to close interatrial communications holes within the oval fossa |
Q77812503 | A new technique for sizing of atrial septal defects |
Q57152275 | A remarkable case of late-onset biatrial bacterial endocarditis of the Gore HELEX septal occluder |
Q36566368 | Accuracy of Transthoracic Echocardiography in Assessing Retro-aortic Rim prior to Device Closure of Atrial Septal Defects |
Q73372592 | Acute animal studies of the STARFlex system: a new self-centering cardioSEAL septal occluder |
Q41958733 | Amplatzer Device closure of Atrial Septal Defects and Patent Ductus Arteriosus: Initial Experience |
Q35369934 | Animal experimental implantation of an atrial septal defect occluder system |
Q38147613 | Balloon dilation catheters |
Q35773432 | Biocompatibility of septal defect closure devices |
Q51801318 | Catheter Closure of Secundum ASD Using “Other” Devices |
Q74485265 | Closure of atrial septal defects with the Amplatzer occlusion device: preliminary results |
Q73662532 | Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following transcatheter device placement |
Q97524959 | Comparison of Two Percutaneous Atrial Septal Defect Occluders for Device Healing and Nickel Release in a Chronic Porcine Model |
Q77220516 | Comparison of the Sideris and Amplatzer septal occlusion devices |
Q78353533 | Comparison of transcatheter closure of secundum atrial septal defect using the Amplatzer septal occluder associated with deficient versus sufficient rims |
Q33911306 | Congenital Heart Surgery Nomenclature and Database Project: therapeutic cardiac catheter interventions |
Q39196071 | Design and Implementation of a Prospective Adult Congenital Heart Disease Biobank |
Q77220904 | Early clinical experience with use of the 'Amplatzer Septal Occluder' device for atrial septal defect |
Q77361732 | Echocardiographic characteristics of successful deployment of the Das AngelWings atrial septal defect closure device: initial multicenter experience in the United States |
Q68179097 | Echocardiographic estimation of balloon-stretched diameter of secundum atrial septal defect for transcatheter occlusion |
Q78727489 | Effect of catheter device closure of atrial septal defect on diastolic mitral annular motion |
Q37358483 | Efficacy and safety of transcatheter closure in adults with large or small atrial septal defects. |
Q38852997 | Endocarditis and Incomplete Endothelialization 12 Years after Amplatzer Septal Occluder Deployment |
Q43019188 | Enhanced prothrombin formation and platelet activation in Chinese patients after transcatheter closure of atrial septal defect |
Q46623051 | Evaluation of the morphology of the oval fossa for placement of devices |
Q73118063 | Experience in one centre using the buttoned device for occlusion of atrial septal defect: comparison with the Amplatzer septal occluder |
Q41022579 | Failure of devices used for closure of atrial septal defects: mechanisms and management |
Q74505274 | Healing response to the Clamshell device for closure of intracardiac defects in humans |
Q74598892 | Immediate and six-month results of the profile of the Amplatzer septal occluder as assessed by transesophageal echocardiography |
Q64282989 | Incomplete endothelialization of WatchmanTM Device: Predictors and Implications from Two Cases |
Q54950353 | Incomplete endothelialization of an intravascular implant and fatal late-onset bacterial ductal arteritis in a dog with occluded patent ductus arteriosus. |
Q77303535 | Inroads in transcatheter therapy for congenital heart disease |
Q40786483 | Interventional catheter procedures used in congenital heart disease. |
Q74220428 | Interventional pediatric cardiology: device closures |
Q33591279 | Interventional procedures for congenital heart disease |
Q34490938 | Is interventional closure the current treatment of choice for selected patients with deficient atrial septation? |
Q51842721 | Late follow-up of nonoperative closure of secundum atrial septal defects using the King-Mills double-umbrella device. |
Q33611914 | Morphological study of defects of the atrial septum within the oval fossa: implications for transcatheter closure of left-to-right shunt |
Q40889068 | Morphological variations of fossa ovalis atrial septal defects (secundum): feasibility for transcutaneous closure with the clam-shell device |
Q72451744 | Nursing implications of interventional device placement in pediatric cardiology and pediatric cardiac surgery |
Q40549433 | Paediatric cardiac catheterization: innovations |
Q82653243 | Pediatric cardiology: then and now |
Q41972184 | Percutaneous closure of secundum atrial septal defect with a new self centering device ("angel wings"). |
Q38075816 | Percutaneous mitral and aortic paravalvular leak repair: indications, current application, and future directions |
Q55076347 | Percutaneous occluder device closure through femoral vein guidance by transthoracic echocardiography in adult atrial septal defect patients. |
Q41554249 | Percutaneous therapy of structural heart disease: pediatric disease |
Q34105104 | Recommendations of the British Paediatric Cardiac Association for therapeutic cardiac catheterisation in congenital cardiac disease |
Q47426990 | Relationship of echocardiographic, shunt flow, and angiographic size to the stretched diameter of the atrial septal defect |
Q40269065 | Rheumatic fever pathogenesis: Approach in research needs change |
Q57300704 | Role of animal models for percutaneous atrial septal defect closure |
Q73906522 | Role of inverted buttoned device in transcatheter occlusion of atrial septal defects or patent foramen ovale with right-to-left shunting associated with previously operated complex congenital cardiac anomalies |
Q61807475 | Serum Nickel and Titanium Levels after Transcatheter Closure of Atrial Septal Defects with Amplatzer Septal Occluder |
Q39534873 | Sizing of atrial septal defects to predict successful closure with transcatheter cardioSEAL device |
Q64251509 | Spontaneous Resolution of Residual Shunting in 2 Compromised Patients after Amplatzer Occlusion of Postinfarction Ventricular Septal Defects |
Q35652411 | Successful closure of a previously unsuspected atrial septal defect by an implantable Clamshell device and subsequent transvenous pacemaker implantation |
Q35579942 | Surgical and transcatheter (Amplatzer) closure of atrial septal defects: a prospective comparison of results and cost |
Q39653469 | The use of anticoagulation in pediatric cardiac disease. |
Q73017380 | Thrombus formation after transcatheter closure of atrial septal defect |
Q68032034 | Transcatheter atrial septal defect occlusion devices: normal radiographic appearances and complications |
Q33716446 | Transcatheter closure of atrial septal defect and interatrial communications with a new self expanding nitinol double disc device (Amplatzer septal occluder): multicentre UK experience. |
Q73200734 | Transcatheter closure of atrial septal defect with a new flexible, self-centering device (the STARFlex Occluder) |
Q34012634 | Transcatheter closure of atrial septal defects using the Cardio-Seal implant |
Q77689143 | Transcatheter closure of atrial septal defects within the oval fossa: medium-term results in children using the 'ASDOS'-technique |
Q41338189 | Transcatheter closure of secundum atrial septal defects with the atrial septal defect occlusion system (ASDOS): initial experience in children |
Q73337773 | Transcatheter coil occlusion of perivalvular mitral leaks associated with severe hemolysis |
Q74629658 | Transcatheter management of ventricular septal rupture after myocardial infarction |
Q37042202 | Transcatheter occlusion of cardiac septal defects |
Q51728000 | Transcatheter patch occlusion of heart defects. |
Q34439983 | Transoesophageal echocardiography during interventional cardiac catheterisation in congenital heart disease. |
Q47327734 | Volume-rendered, three-dimensional echocardiographic determination of the size, shape, and position of atrial septal defects: validation in an in vitro model |
Q74601184 | [Percutaneous closure of atrial septal defect with the Amplatz device: initial result and mid-term follow-up] |